Monday, July 23rd, 2012

Biotechnology company Catalyst Medical, which develops pathways to market for medical device technologies, will be featured at the Melbourne Investor Opportunity and Networking Evening on Monday, the 23rd of July 2012. The event is taking place at PwC Melbourne Freshwater Pl from 6:30 p.m. - 8:00 p.m. All media are invited to attend.

It is estimated that around 350 original patents are filed annually in Australia covering concepts for new medical devices, and yet most of these never reach commercialization. One Australian based company believes that it can assist some of these concepts find a pathway to market locally, regionally and globally.

Australasian company Catalyst Medical believes that these devices, and other technologies being developed in Australia, New Zealand and elsewhere in the Asia Pacific, offer great commercial opportunities to an organization with the right expertise and contacts.

Catalyst Medical chief executive Peter Hickey says the company’s strategy is “to find the best three to five” of these new medical devices, help develop them and bring them to market.

“We feel that we can really help to get some of the really good ideas commercialized throughout the Asia Pacific,” says Hickey, who has had a 30 year career in the health industry, including as Managing Director of a leading multi-national in Australia, NZ and Southeast Asia.

“We will identify the best technologies and work with our networks to prove the concepts of the technology whilst developing a unique market strategy for the technology.”

Formed in April 2011, Catalyst Medical has already taken two products to the market: a keratin-based healing product for wounds which was developed in Christchurch NZ, and a new Silver based wound dressing product which delivers high quality clinical outcome with excellent financial returns for clinicians. This product has been launched in NZ and is set for regulatory approval soon in Australia. Expansion plans into other Global Markets are underway for these two technologies under the Catalyst brand and revenues earned will be used to assist our commercialization of new technology and IP.

“We are already getting revenue from those products, and the plan now is to use that revenue and turn that back into finding other devices and technologies,” says Peter Hickey.

Catalyst Medical is seeking to raise between $250,000 and $500,000, and will use those funds to expand its headcount with experienced staff to manage distributor relationships and expand the use of its product list.

That will also enable Peter Hickey and his management team to closely examine new products from incubators and universities in the region, and bring new products to the market.

Catalyst Medical is one of five companies presenting at the Wholesale Investor Opportunity and Networking Evening in Melbourne on Monday July 23.

The event takes place at the PwC Offices, Freshwater Place, Level 19, 2 Southbank Boulevard from 6.30-8pm

For more information go to

Contact Profile

Steve Torso, Managing Director, Wholesale Investor

P: 1300 597 595


Around 350 original patents are filed annually in Australia covering concepts for new medical devices



More Formats

View QR Code